Ann H. Partridge

机构：Brigham and Women's Hospital, Harvard University, Dana-Farber Cancer Institute, Dana-Farber Brigham Cancer Center · ORCID：0000-0002-4722-4824

发表论文 1065 篇 · 总被引 47511 次 · h-index 103

代表论文

• Updated results of the POSITIVE (Pregnancy Outcome and Safety of Interrupting Therapy for Women with Endocrine Responsive Breast Cancer) trial (2026 · Annals of Oncology · 被引 4)
• Abstract GS1-03: Adjuvant aromatase inhibitor or tamoxifen in patients with hormone receptor-positive/HER2-positive early breast cancer: An exploratory analysis from the ALTTO (BIG 2-06) trial (2026 · Clinical Cancer Research · 被引 3)
• Radiation therapy management in BRCA1/2 carriers diagnosed with early breast cancer: An international cohort study (2026 · Radiotherapy and Oncology · 被引 2)
• Effect of a weight loss intervention (WLI) on quality of life (QOL) and symptoms in women with breast cancer: Results from the Breast Cancer Weight Loss (BWEL) trial. (2026 · Journal of Clinical Oncology · 被引 1)
• Impact of germline BRCA pathogenic or likely pathogenic variants on fertility potential and reproductive outcomes in young women with breast cancer: A systematic review and meta-analysis. (2026 · Journal of Clinical Oncology · 被引 1)
• Pregnancy history, recency of childbirth, and outcomes in young women with early-stage breast cancer (2026 · JNCI Journal of the National Cancer Institute · 被引 1)